Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Expanding the applicability of a multicomponent nano-quantitative structure-property relationships approach from hard to soft nanomaterials: predicting liposome stability.

Nanoscale·2026
Same author

Modelling an alternative lipophilicity scale of bisphenols using biomimetic chromatography: Relevance to membrane-driven baseline toxicity.

ADMET & DMPK·2026
Same author

Computationally predicted persistence of micro- and nanoplastics: Decay of polyethylene terephthalate in neutral, acidic and alkaline media.

Journal of hazardous materials·2026
Same author

Toward In Silico NAMs Analysis of Thyroid Disruption Leading to Developmental Neurotoxicity─A Collection of AOP-Anchored Computational Models.

Chemical research in toxicology·2026
Same author

Can we integrate plasma protein binding data into IATA using new approach methodologies? A case study on bisphenol analogs.

Chemico-biological interactions·2026
Same author

An integrative omics-machine learning framework for predicting pulmonary responses to titanium dioxide nanoparticles.

Nanoscale·2026
Same journal

Anomalous Hall effect in room-temperature two-dimensional van der Waals ferromagnets.

Nanoscale horizons·2026
Same journal

Light-induced acceleration of specific binding between CEACAM-5 and antibodies for early detection of colorectal cancer.

Nanoscale horizons·2026
Same journal

Study on the anti-inflammatory effect of tetrahedral framework nucleic acid-loaded sinomenine in the treatment of rheumatoid arthritis.

Nanoscale horizons·2026
Same journal

Enhancing photodynamic and chemodynamic therapy efficacy through a novel ROS-amplifying therapeutic platform for breast cancer treatment.

Nanoscale horizons·2026
Same journal

Acacetin-incorporated lipid nanoparticles for inhaled mRNA vaccines.

Nanoscale horizons·2026
Same journal

Nanofluidic systems for ionic intelligence.

Nanoscale horizons·2026
関連記事をすべて見る

関連する実験動画

Updated: Jun 1, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

9.6K

ナノ毒性学におけるTRIumph:トランスクリプトミクスを単一の予測変数に簡素化する

Viacheslav Muratov1, Karolina Jagiello1,2, Tomasz Puzyn1,2

  • 1University of Gdansk, Faculty of Chemistry, Laboratory of Environmental Chemoinformatics, Wita Stwosza 63, 80-308 Gdansk, Poland. karolina.jagiello@ug.edu.pl.

Nanoscale horizons
|September 3, 2025
PubMed
まとめ
この要約は機械生成です。

複合的な遺伝子発現データを単一の変数に簡素化する新型トランスクリプトミック応答指数 (TRI) が開発されました. このTRIは,多壁の炭素ナノチューブ特性とリンクし,正確な予測を可能にし,計算の必要性を軽減します.

さらに関連する動画

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.4K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

892

関連する実験動画

Last Updated: Jun 1, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

9.6K
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.4K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

892

科学分野:

  • トキシゲノミクス
  • コンピュータ生物学
  • ナノ毒性学

背景:

  • トランスクリプトミックのデータ分析は,高次元性のために課題を提示します.
  • 既存の方法はかなりの計算リソースを必要とします.
  • 動物実験を減らすために新しいアプローチの方法論 (NAM) の必要性

研究 の 目的:

  • トランスクリプトミックのデータを簡素化するために新しいトランスクリプトミックの応答指数 (TRI) を導入する.
  • TRIを吸入された多壁炭素ナノチューブ (MWCNT) の物理化学的性質と関連付けます.
  • MWCNTの特性に基づく遺伝子発現変化の予測モデルを開発する.

主な方法:

  • トランスクリプトミック・レスポンス・インデックス (TRI) を開発し,トランスクリプトミック空間を単一の変数に圧縮した.
  • 定量構造-活性関係 (QSAR) とナノQSARモデルを使用した.
  • 何千もの差異的に発現する遺伝子 (DEGs) の折り畳み変化を訓練したモデル.

主要な成果:

  • TRIは5167のDEGを単一の変数に圧縮し,トランスクリプトミックの99.9%を説明しました.
  • TRIとMWCNTの性質を結びつけるナノQSARモデルは,高い統計的有意性を達成した (R2=0.83,Q_CV2=0.8,Q2=0.78).
  • 単一の変数を用いて遺伝子発現の変化を予測する能力を示した.

結論:

  • TRIはトランスクリプトミックの複雑さを管理する強力なアプローチを提供します.
  • この方法論は,動物実験と計算負荷を減らすことで,NAMをサポートします.
  • 規制科学における機械学習モデル開発のためのユーザーフレンドリーなツールであるChemBioMLプラットフォームを開発しました.